Evidence map›Paper›PMID 32748894›Full record

ArticleInternational journal of molecular sciences2020

Chrysin Inhibits High Glucose-Induced Migration on Chorioretinal Endothelial Cells via VEGF and VEGFR Down-Regulation.

Zhen-Yu Liao, I-Chia Liang, Hsin-Ju Li, Chia-Chun Wu, Huey-Ming Lo, Der-Chen Chang, Chi-Feng Hung

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Synthesis,Journal of enzyme inhibition and medicinal chemistry · 2025
    Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Three-dimensional spheroids of choroid-retinal vascular endothelial cells as anCurrent research in pharmacology and drug discovery · 2022
    Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Zhen-Yu LiaoDepartment of Internal Medicine, Shin Kong Wu Ho-Su Memorial Hospital, Taipei 111, Taiwan.
I-Chia LiangDepartment of Ophthalmology, Tri-Service General Hospital, National Defense Medical Center, Taipei 11490, Taiwan.
Hsin-Ju LiSchool of Medicine, Fu Jen Catholic University, New Taipei City 24205, Taiwan.
Chia-Chun WuGraduate Institute of Biomedical and Pharmaceutical Science, Fu Jen Catholic University, New Taipei City 24205, Taiwan.
Huey-Ming LoDivision of Cardiology, Fu Jen Catholic University Hospital, New Taipei City 24205, Taiwan.
Der-Chen ChangDepartment of Mathematics and Statistics and Department of Computer Science, Georgetown University, Washington, DC 20057, USA.
Chi-Feng HungSchool of Medicine, Fu Jen Catholic University, New Taipei City 24205, Taiwan.ORCID 0000-0003-3478-5451
Fu Jen Catholic University · TWGeorgetown University · US

Funding

Ministry of Science and Technology, Taiwan MOST107-2320-B-030-003-MY3Shin Kong Wu Ho-Su Memorial Hospital 105-SKH-FJU-05
6 · The paper itself

Abstract

backgroundDiabetes mellitus (DM) is a chronic inflammatory disease, which causes multiple complications. Diabetic retinopathy (DR) is among these complications and is a dominant cause of vision loss for diabetic patients. Numerous studies have shown that chrysin, a flavonoid, has many biological activities such as anti-oxidation and anti-inflammation. However, it is rarely used in ocular diseases. In this study, we examined the inhibitory effects of flavonoid on high glucose induced migration of chorioretinal endothelial cells (RF/6A cells) and its mechanism. MATERIALS AND

methodsThe viability of RF/6A cells treated with chrysin was examined with a 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay. The migration of RF/6A cells was assessed by the transwell migration and scratch wound assays. The expression of AKT, ERK, vascular endothelial growth factor (VEGF), HIF-1α and MMP-2 were determined by western blotting. To observe the mRNA expression of VEGF receptor (VEGFR), qRT-PCR, was utilized.

resultsThe results showed that chrysin can dose-dependently inhibit the RF/6A cell migration in vitro transwell and the scratch wound assays which are induced by high glucose. After pretreatment of RF/6A cells with different concentrations of chrysin, they did not produce any cytotoxicity in MTT assay. Moreover, chrysin down-regulated both phosphorylated AKT and ERK, as well as attenuated the expression levels of MMP-2. It also decreased the expression of the VEGF transcription factor and VEGF. Furthermore, it was shown that chrysin could suppress the protein and mRNA expression levels of VEGFR.

conclusionThe results indicate that chrysin could down-regulate the phosphorylation of AKT, ERK and MMP-2 and reduce the effects of VEGF and VEGFR in a high glucose environment. It further inhibits the high glucose-induced migration of RE/6A cells. Therefore, chrysin may have the potential for visual protection.

Indexed as

AnimalsCell LineCell MovementCell SurvivalDown-RegulationEndothelial CellsExtracellular Signal-Regulated MAP KinasesFlavonoidsGene ExpressionGlucoseMacaca mulattaMatrix Metalloproteinase 2PhosphorylationProto-Oncogene Proteins c-aktReceptors, Vascular Endothelial Growth FactorVascular Endothelial Growth Factor AchrysinExtracellular Signal-Regulated MAP KinasesFlavonoidsGlucoseMatrix Metalloproteinase 2Proto-Oncogene Proteins c-aktReceptors, Vascular Endothelial Growth FactorVascular Endothelial Growth Factor Achorioretinal endothelial cellchrysinhigh glucosevascular endothelial growth factor (VEGF)

Identifiers

PMID32748894
PMCPMC7432058
OpenAlexW3046258871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.